Icagen, Inc. (FRA:ICFN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On March 15, 2017, the Board of Directors (the Board) of Icagen,
Inc. (the Company) granted under the Companys 2015 Stock
Incentive Plan (the Plan) the following: (i) options to purchase
10,000 shares of common stock, par value $0.001 per share of the
Company (the Common Stock) to each of the Companys five
non-employee members of the Board (which equals options to
purchase an aggregate of 50,000 shares of Common Stock); and (ii)
options to purchase 20,000 shares of Common Stock to Richie
Cunningham, the Companys Chief Executive Officer. All of the
stock options granted have an exercise price of $3.50 per share,
vest monthly on a pro rata basis over a three year period and
expire ten years after the date of grant. In addition, the Board
approved a bonus to Mr. Cunningham of 70% of his base pay
together with the options mentioned above and a merit increase in
his base salary of 2.5%.
Icagen, Inc. (FRA:ICFN) Recent Trading Information
Icagen, Inc. (FRA:ICFN) closed its last trading session at 4.20 with shares trading hands.